News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
367,693 Results
Type
Article (24659)
Company Profile (99)
Press Release (342933)
Multimedia
Podcasts (50)
Webinars (10)
Section
Business (100999)
Career Advice (1188)
Deals (16905)
Drug Delivery (56)
Drug Development (50618)
Employer Resources (99)
FDA (9164)
Job Trends (8743)
News (178768)
Policy (16378)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
Academia (1993)
Accelerated approval (15)
Adcomms (16)
Allergies (68)
Alliances (25997)
ALS (114)
Alzheimer's disease (1253)
Antibody-drug conjugate (ADC) (183)
Approvals (9442)
Artificial intelligence (292)
Autoimmune disease (92)
Automation (22)
Bankruptcy (168)
Best Places to Work (7004)
BIOSECURE Act (7)
Biosimilars (106)
Biotechnology (63)
Bladder cancer (129)
Brain cancer (37)
Breast cancer (387)
Cancer (2949)
Cardiovascular disease (276)
Career advice (994)
Career pathing (29)
CAR-T (169)
CDC (25)
Cell therapy (431)
Cervical cancer (23)
Clinical research (43450)
Collaboration (1043)
Company closure (3)
Compensation (452)
Complete response letters (27)
COVID-19 (1482)
CRISPR (55)
C-suite (458)
Cystic fibrosis (88)
Data (4406)
Denatured (11)
Depression (83)
Diabetes (332)
Diagnostics (3477)
Digital health (19)
Diversity (3)
Diversity, equity & inclusion (23)
Drug discovery (160)
Drug pricing (72)
Drug shortages (17)
Duchenne muscular dystrophy (173)
Earnings (39624)
Editorial (22)
Employer branding (17)
Employer resources (86)
Events (53113)
Executive appointments (583)
FDA (11183)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (18)
Funding (807)
Gene editing (121)
Generative AI (29)
Gene therapy (444)
GLP-1 (633)
Government (2784)
Grass and pollen (1)
Guidances (291)
Healthcare (10980)
HIV (35)
Huntington's disease (24)
IgA nephropathy (69)
Immunology and inflammation (148)
Immuno-oncology (31)
Indications (72)
Infectious disease (1632)
Inflammatory bowel disease (118)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (149)
Interviews (191)
IPO (7865)
IRA (25)
Job creations (1960)
Job search strategy (868)
JPM (33)
Kidney cancer (12)
Labor market (48)
Layoffs (340)
Leadership (18)
Legal (2876)
Liver cancer (59)
Longevity (7)
Lung cancer (378)
Lymphoma (265)
Machine learning (22)
Management (31)
Manufacturing (400)
MASH (170)
Medical device (6647)
Medtech (6678)
Mergers & acquisitions (9605)
Metabolic disorders (866)
Multiple sclerosis (104)
NASH (19)
Neurodegenerative disease (203)
Neuropsychiatric disorders (52)
Neuroscience (2078)
Neurotech (1)
NextGen: Class of 2026 (3693)
Non-profit (2973)
Now hiring (54)
Obesity (360)
Opinion (168)
Ovarian cancer (88)
Pain (146)
Pancreatic cancer (130)
Parkinson's disease (193)
Partnered (22)
Patents (258)
Patient recruitment (287)
Peanut (31)
People (32009)
Pharmaceutical (24)
Pharmacy benefit managers (10)
Phase 1 (12964)
Phase 2 (19146)
Phase 3 (14924)
Pipeline (3495)
Policy (130)
Postmarket research (1646)
Preclinical (5902)
Press Release (35)
Prostate cancer (144)
Psychedelics (23)
Radiopharmaceuticals (161)
Rare diseases (530)
Real estate (3433)
Recruiting (43)
Regulatory (13368)
Reports (22)
Research institute (1588)
Resumes & cover letters (190)
Rett syndrome (25)
RNA editing (14)
RSV (44)
Schizophrenia (125)
Series A (134)
Series B (90)
Service/supplier (4)
Sickle cell disease (59)
Special edition (9)
Spinal muscular atrophy (107)
Sponsored (21)
Startups (2213)
Stomach cancer (6)
Supply chain (51)
Tariffs (20)
The Weekly (38)
Vaccines (529)
Venture capital (54)
Weight loss (212)
Women's health (43)
Worklife (10)
Date
Today (51)
Last 7 days (293)
Last 30 days (1103)
Last 365 days (17455)
2026 (1578)
2025 (17675)
2024 (20395)
2023 (22961)
2022 (30786)
2021 (32108)
2020 (30099)
2019 (26416)
2018 (19967)
2017 (18132)
2016 (17242)
2015 (19954)
2014 (14073)
2013 (11073)
2012 (12055)
2011 (12476)
2010 (10769)
Location
Africa (442)
Alabama (26)
Alaska (2)
Arizona (107)
Arkansas (7)
Asia (20742)
Australia (3515)
California (6543)
Canada (1890)
China (675)
Colorado (250)
Connecticut (248)
Delaware (193)
Europe (50112)
Florida (883)
Georgia (220)
Hawaii (4)
Idaho (31)
Illinois (507)
India (53)
Indiana (324)
Iowa (15)
Japan (308)
Kansas (92)
Kentucky (20)
Louisiana (22)
Maine (36)
Maryland (716)
Massachusetts (4416)
Michigan (205)
Minnesota (282)
Mississippi (5)
Missouri (65)
Montana (15)
Nebraska (16)
Nevada (61)
New Hampshire (43)
New Jersey (1992)
New Mexico (13)
New York (1703)
North Carolina (842)
North Dakota (5)
Northern California (3213)
Ohio (216)
Oklahoma (6)
Oregon (29)
Pennsylvania (1221)
Puerto Rico (11)
Rhode Island (16)
South America (575)
South Carolina (22)
South Dakota (1)
Southern California (2569)
Tennessee (93)
Texas (975)
United States (22553)
Utah (181)
Virginia (122)
Washington D.C. (39)
Washington State (583)
West Virginia (3)
Wisconsin (55)
367,693 Results for "baybio bay area bioscience association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bacterial Mechanism That Could Help Prevent and Treat Lyme Arthritis Identified by New Bay Area Lyme Foundation–Supported Study
January 21, 2026
·
4 min read
Earnings
AbbVie’s I&I Portfolio Sells $30 Billion but Execs Again Underline Other Areas
On its fourth quarter earnings call Wednesday, AbbVie CEO Robert Michael called oncology and neuroscience “underappreciated” areas of focus for the pharma.
February 4, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore
December 2, 2025
·
5 min read
Job Trends
California’s $23.9M in Life Sciences Grants Could Add 10,000 Jobs in LA Area
Four Los Angeles County life sciences projects are receiving funding to support goals that include adding jobs, creating multitenant facilities for graduation-stage companies, financially supporting emerging businesses and attracting large employers to the area.
September 10, 2025
·
2 min read
·
Angela Gabriel
Job Trends
High-Growth Areas, Development Roles May Offer More Job Security
With layoffs happening at biopharma companies of all sizes, some may wonder which jobs are safest. Talent acquisition experts spoke to
BioSpace
about the areas and roles they recommend to biotech and pharma professionals hoping to avoid staff cuts.
October 2, 2025
·
4 min read
·
Angela Gabriel
Press Releases
Integrated DNA Technologies Brings Innovation Nexus to San Francisco Bay Area
May 5, 2025
·
3 min read
Business
Spruce Biosciences Recognized as a Bay Area Best Place to Work
Spruce Biosciences, Inc. announced that the San Francisco Business Times and the Silicon Valley Business Journal have recognized the company as a Best Place to Work in 2024.
June 6, 2024
·
2 min read
Genetown
Gilead Sciences CEO on Company’s Evolution and Commitment to the Bay Area
Today the Foster City-based company is the second-largest biotech employer in the Bay Area.
March 5, 2024
·
1 min read
Business
Chicago Area’s Life Sciences Scene Continues Making an Impression
While the Chicago metropolitan area is not a major life sciences hub, a recent Cushman & Wakefield report predicts the Chicago market should be a growth spot in the coming years. Chicago Biomedical Consortium and COUR Pharmaceuticals executives share what makes the area a hot spot.
January 30, 2025
·
6 min read
·
Angela Gabriel
Business
Amit Etkin, M.D., Ph.D., Founder and CEO of Alto Neuroscience, Named an EY Entrepreneur Of The Year® 2024 Bay Area Award Winner
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced that Amit Etkin, M.D., Ph.D., founder and CEO, was named an Entrepreneur Of The Year® 2024 Bay Area Award finalist by EY.
June 18, 2024
·
4 min read
1 of 36,770
Next
